Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Adaltis, an in vitro diagnostic company, has elected Peter Bambic to succeed Pierre Larochelle as its president and CEO. The company has also elected Mr Bambic to its board of directors.
Subscribe to our email newsletter
Mr Larochelle will remain on the board of directors of Adaltis and will ensure a smooth executive leadership transition, working with Mr Bambic in his new role.
Most recently, Mr Bambic was a member of Ortho Clinical Diagnostics, a Johnson and Johnson Company where he was national account director of US distributor sales. Mr Bambic holds a PhD in business administration from Penn State University.
Michelle Cormier, chairman of the board of directors of Adaltis said: “The election of Peter Bambic as the new president and CEO of Adaltis comes at a very exciting time in the history of the company, as we are heading into an accelerated period of growth with the launch of Eclectica and the growing prospects opening up in China.”